MedTrace Logo

trūFreeze® Spray Cryotherapy Patient Registry

NCT01802203 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 275

Last updated 2022-07-25

No results posted yet for this study

Summary

To collect efficacy and outcomes data related to the use of trūFreeze® spray cryotherapy for the treatment of unwanted tissue in the pulmonary and gastrointestinal settings.

Conditions

  • Barrett Esophagus
  • Esophageal Dysplasia
  • Esophageal Neoplasm
  • Esophageal Stenosis
  • Bronchial Neoplasm
  • Stenosis of Bronchus or Trachea

Interventions

DEVICE

truFreeze Spray Cryotherapy

spray cryotherapy

Sponsors & Collaborators

  • US Endoscopy Group Inc.

    lead INDUSTRY

Principal Investigators

  • Nicholas Shaheen, MD · University of North Carolina, Chapel Hill

  • Robert F Browning, MD · Walter Reed National Military Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2022-01-31
Completion
2022-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01802203 on ClinicalTrials.gov